Gitelman Syndrome - 3 Studies Found
Completed |
: Input of the Use of Indometacin in Gitelman Syndrome as Compared to Potassium Sparing Diuretics : Gitelman Syndrome : 2010-06-16 : Drug: TREATMENT Patients with received in random order 75mg/day indometacin(chronoindocid®), 10-20 |
Completed |
: Monocentric STUDY, Randomised Double Blinded (Healthy Subjects, or Transversal (Patients With Gitelman Syndrome) :
: 2014-10-29 : Dietary Supplement: Potassium depletion Healthy subjects will be submitted twice at 15-30 day interval, |
Completed |
: Clinical Significance of Heterozygosity for Mutations of the SLC12A3 Gene Coding for the Thiazide Sensitive Na-Cl Cotransporter : Heterozygous Carriers of Gitelman Syndrome : 2013-12-18 :
|